Background illustration for clinical trials search

Prostate Cancer Clinical Trials

Browse 764 prostate cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: New Haven CT, Orlando FL, Toronto, Nashville TX,
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT05800665

Phase1, Recruiting
Featured

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

for
Advanced Prostate Cancer, Metastatic Prostate Cancer
Location: Nashville TN, Scottsdale AZ
Sponsor: Genentech, Inc.

Sex: Male

Age: 18+

Code: NCT07567846

Phase1, Phase2, Recruiting
Featured

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Providence RI, The Bronx NY, Montreal, Myrtle Beach SC,
Sponsor: Hoffmann-La Roche

Sex: Male

Age: 18+

Code: NCT07287150

Phase2, Recruiting
Active & Responsive

Understanding of Genetics by Men at Risk for Prostate Cancer

for
Prostate Cancer
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Mayo Clinic

Sex: Male

Age: 40 - 70+

Code: NCT04550845

Recruiting
Active & ResponsiveNew

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

for
Prostate Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: Male

Age: 18+

Code: NCT07226713

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & ResponsiveNew

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

for
Metastatic Castration-Resistant Prostate Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07698535

Phase2, Recruiting
Active & ResponsiveNew

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

for
Prostate Cancer Screening
Location: Durham NC, Hardeeville SC
Sponsor: Uro-1 Medical

Sex: Male

Age: 18+

Code: NCT06830265

Recruiting
Active & Responsive

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health

Sex: All

Age: 18+

Code: NCT06559059

Recruiting
Active & Responsive

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

for
Prostate Cancer
Location: New York NY
Sponsor: SpectraCure AB

Sex: Male

Age: 18+

Code: NCT06807359

Phase1, Phase2, Recruiting
Active & Responsive

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: Male

Age: 0+

Code: NCT06145633

Phase2, Recruiting
Active & Responsive

PET/CT Characterization of Treatment Resistance

for
Prostate Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT05647564

Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: VA Office of Research and Development

Sex: Male

Age: 18+

Code: NCT04038502

Phase2, Recruiting
Active & Responsive

Real World Prostate Cancer Registry

for
Prostate Cancer
Location: Cincinnati OH
Sponsor: Cincinnati Cancer Advisors

Sex: Male

Age: 18+

Code: NCT06355336

Recruiting
Active & Responsive

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

for
Metastatic Prostate Carcinoma,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Male

Age: 18+

Code: NCT05627219

Recruiting
Active & Responsive

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

for
Prostate Cancer
Location: San Francisco CA
Sponsor: Robert Bok, MD, PhD

Sex: Male

Age: 18+

Code: NCT06391034

Phase2, Recruiting
Active & Responsive

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

for
Prostate Cancer
Location: Indianapolis IN, Carmel IN
Sponsor: Indiana University

Sex: Male

Age: 40+

Code: NCT05879913

Recruiting
Active & Responsive

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

for
Metastatic Castration-Resistant Prostate Cancer
Location: Columbia MD, Fairfax VA, Margate FL, Plantation FL,
Sponsor: Zenith Epigenetics

Sex: Male

Age: 18+

Code: NCT04986423

Phase2, Recruiting
Active & Responsive

EDRN Prostate MRI Biomarker Study

for
PSA, Prostate Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan

Sex: Male

Age: 18+

Code: NCT03784924

Recruiting
Active & Responsive

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

for
Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Male

Age: 18+

Code: NCT05852041

Early_phase1, Recruiting